Download Free Sample Report

Cell Therapy Manufacturing Market, Global Outlook and Forecast 2023-2032

Cell Therapy Manufacturing Market, Global Outlook and Forecast 2023-2032

  • Published on : 09 February 2023
  • Pages :111
  • Report Code:SMR-7555939

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

This report contains market size and forecasts of Cell Therapy Manufacturing in Global, including the following market information:
Global Cell Therapy Manufacturing Market Revenue, 2018-2023, 2023-2032, ($ millions)
Global top five companies in 2022 (%)
The global Cell Therapy Manufacturing market was valued at US$ million in 2022 and is projected to reach US$ million by 2032, at a CAGR of % during the forecast period 2023-2032.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2032.
Autologous Segment to Reach $ Million by 2032, with a % CAGR in next six years.
The global key manufacturers of Cell Therapy Manufacturing include Merck KGaA, Avantor, Cell Therapies, Thermo Fisher Scientific, Charles River Laboratories, Catalent, Bio-Techne, Cytiva and Lonza, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cell Therapy Manufacturing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell Therapy Manufacturing Market, by Type, 2018-2023, 2023-2032 ($ millions)
Global Cell Therapy Manufacturing Market Segment Percentages, by Type, 2022 (%)
Autologous
Allogenic
Global Cell Therapy Manufacturing Market, by Application, 2018-2023, 2023-2032 ($ millions)
Global Cell Therapy Manufacturing Market Segment Percentages, by Application, 2022 (%)
HIV
Autoimmune Disorders
Immune Deficiencies
Cancer
Neurological Disorders
Global Cell Therapy Manufacturing Market, By Region and Country, 2018-2023, 2023-2032 ($ Millions)
Global Cell Therapy Manufacturing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cell Therapy Manufacturing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cell Therapy Manufacturing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck KGaA
Avantor
Cell Therapies
Thermo Fisher Scientific
Charles River Laboratories
Catalent
Bio-Techne
Cytiva
Lonza
The Discovery Labs
BIOCENTRIQ
FUJIFILM Diosynth Biotechnologies
Novartis AG
Bristol-Myers Squibb
Gilead Sciences
WuXi AppTec
OXGENE
Pharmaron
Aldevron
FLODESIGN SONICS
Exothera